Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial

Jesper Jensen, Massar Omar, Caroline Kistorp, Mikael Kjær Poulsen, Christian Tuxen, Ida Gustafsson, Lars Køber, Finn Gustafsson, Jens Faber, Emil L Fosbøl, Niels Eske Bruun, Jan Christian Brønd, Julie Lyng Forman, Lars Videbæk, Jacob Eifer Møller, Morten Schou

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Fingeraftryk

Udforsk hvilke forskningsemner 'Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial' indeholder.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science